文献速递母胎医学

CNV-seq在产前诊断中检测胎儿DMD基因缺失或重复的效能

[Efficiency of CNV-seq in detecting fetal DMD gene deletion or duplication in prenatal diagnosis].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2024-01-01

回顾性分析云南省第一人民医院2018年1月至2023年7月34 544例产前诊断胎儿中156例CNV-seq结果,以MLPA为金标准,CNV-seq检出DMD基因缺失或重复的总符合率92.3%(144/156),敏感度和阳性预测值均为88.2%,特异度和阴性预测值均为94.3%,漏检率3.8%,Kappa系数0.839,结论为CNV-seq有效但建议MLPA验证。

要点

  • CNV-seq检测胎儿DMD基因缺失或重复与MLPA总符合率92.3%(144/156),Kappa系数0.839。
  • 有DMD/BMD家族史胎儿中MLPA检出20例缺失和6例重复,其中4例缺失和2例重复因片段<100 Kb被CNV-seq漏检。
  • 无家族史胎儿中CNV-seq检出重复占58%(18/31),高于有家族史胎儿,chrX:32650635_32910000区域重复MLPA均为阴性。

核心结论

  • CNV-seq可有效检出胎儿DMD基因缺失或重复,但存在少量漏检风险,结果需MLPA验证。
  • CNV-seq检测到chrX:32650635_32910000区域重复及覆盖DMD基因5′端或3′端重复的变异可能并不致病。

研究设计与样本

  • 回顾性分析2018年1月至2023年7月于云南省第一人民医院行产前诊断的34 544例胎儿CNV-seq结果,纳入156例胎儿。
  • 组1为有DMD/BMD生育史或家族史的胎儿125例,组2为无DMD/BMD生育史或家族史但CNV-seq检出DMD基因缺失或重复的胎儿31例。
  • 以MLPA为标准方法对全部156例进行验证,对CNV-seq和MLPA结果进行一致性检验。

主要发现

  • 与MLPA相比,CNV-seq对胎儿DMD基因缺失或重复的检出总符合率为92.3%(144/156),敏感度和阳性预测值均为88.2%,特异度和阴性预测值均为94.3%,漏检率为3.8%,Kappa系数为0.839。
  • 组1中MLPA共检出20例缺失和6例重复,其中4例缺失和2例重复因变异片段<100 Kb被CNV-seq漏检。
  • 组2中CNV-seq检出缺失占42%(13/31),重复占58%(18/31),重复占比高于组1。
  • 组2的18例重复中,3例位于第42~67号外显子(可能致病),9例覆盖DMD基因5′或3′末端且包含第1或第79号外显子(临床意义未明),其余6例位于chrX:32650635_32910000(临床意义未明),MLPA检测结果均为阴性。

关键数值与推荐

  • CNV-seq对胎儿DMD基因缺失或重复的检出总符合率92.3%(144/156),敏感度88.2%,阳性预测值88.2%,特异度94.3%,阴性预测值94.3%,漏检率3.8%,Kappa系数0.839。
  • 组1中MLPA检出20例缺失和6例重复,CNV-seq漏检4例缺失和2例重复,漏检原因为变异片段<100 Kb。
  • 组2中CNV-seq检出缺失13/31(42%),重复18/31(58%)。
  • 组2的18例重复中,3例位于第42~67号外显子(可能致病),9例覆盖DMD基因5′或3′末端且包含第1或第79号外显子(临床意义未明),6例位于chrX:32650635_32910000(临床意义未明)。

临床怎么用

  • 作者建议CNV-seq检测胎儿DMD基因缺失或重复后,进一步行MLPA验证。
  • 作者认为CNV-seq检测到chrX:32650635_32910000区域重复及覆盖DMD基因5′端或3′端重复的变异应仔细验证和评估,因其可能为非致病性多态性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the diagnostic efficiency of copy number variation sequencing (CNV-seq) to detect the deletion or duplication of DMD gene in prenatal diagnosis. Methods: A retrospective analysis was carried out on the CNV-seq results of 34 544 fetuses diagnosed in the First People's Hospital of Yunnan Province from January 2018 to July 2023. A total of 156 cases of fetuses were collected, including Group 1:125 cases with family history of Duchenne muscular dystrophy or Becker muscular dystrophy (DMD/BMD), and Group 2:31 cases with no family history but a DMD gene deletion or duplication was detected unexpectedly by CNV-seq. Multiplex ligation-dependent probe amplification (MLPA) was used as a standard method to detect the deletion or duplication. Consistency test was carried out basing on the results of CNV-seq and MLPA of all 156 cases. Results: Comparing to MLPA, CNV-seq had a coincidence rate of 92.3% (144/156) for DMD gene deletion or duplication, with a sensitivity and positive predictive value of 88.2%, with a specificity and negative predictive value of 94.3%, a missed detection rate of 3.8%, and a Kappa value of 0.839. CNV-seq missed 4 cases with deletions and 2 with duplications due to involved fragments less than 100 Kb, among 20 cases of deletions and 6 cases of duplications detected by MLPA in Group 1. In Group 2, the deletions and duplications detected by CNV-seq were 42% (13/31) and 58% (18/31), respectively, in which the percentage of duplication was higher than that in Group 1. Among those 18 cases with duplications, 3 cases with duplication locating in exon 42~67 were likely pathogenic; while 9 cases with duplication covering the 5' or 3' end of the DMD gene, containing exon 1 or 79 and with only one breakpoint within the gene, along with the last 6 cases with duplications locating at chrX: 32650635_32910000 detected only by CNV-seq, which might be judged as variants of uncertain significance. Conclusions: CNV-seq has a good efficiency to detect fetal DMD gene deletion or duplication in prenatal diagnosis, while a further verification test by MLPA is recommended. The duplications on chrX: 32650635_32910000, 5' or 3' end of DMD gene detected by CNV-seq should be carefully verified and assessed because those variants appear to be nonpathogenic polymorphisms. 目的: 评估产前诊断中采用低深度高通量全基因组拷贝数变异测序(CNV-seq)技术对胎儿DMD基因缺失或重复的诊断效能。 方法: 对2018年1月至2023年7月于云南省第一人民医院行产前诊断的34 544例胎儿的CNV-seq检测结果进行回顾性分析,共纳入156例胎儿,包括:有假性肥大型进行性肌营养不良[DMD;包括表型较轻的贝氏肌营养不良(BMD)]生育史或家族史的胎儿125例;无DMD/BMD生育史或家族史但因其他指征行产前诊断检出DMD基因缺失或重复的胎儿31例。采用多重连接依赖性探针扩增(MLPA)技术对胎儿样本进行检测验证,对CNV-seq和MLPA结果进行一致性检验,获得CNV-seq对胎儿DMD基因缺失或重复的检测效能。 结果: 与MLPA相比,CNV-seq对胎儿DMD基因缺失或重复的检出总符合率为92.3%(144/156),敏感度和阳性预测值均为88.2%,特异度和阴性预测值均为94.3%,漏检率为3.8%,Kappa系数为0.839。有DMD/BMD生育史或家族史的胎儿中,MLPA共检出20例缺失和6例重复,其中4例缺失和2例重复因变异片段<100 Kb被CNV-seq漏检。无DMD/BMD生育史或家族史的胎儿中,CNV-seq检出缺失占42%(13/31),重复占58%(18/31),重复占比高于有DMD/BMD生育史或家族史的胎儿,其中3例位于第42~67号外显子(可能致病),9例覆盖DMD基因5’或3’末端,均包含第1或第79号外显子(临床意义未明),其余6例CNV-seq检出重复片段位于chrX:32650635_32910000(临床意义未明),但MLPA检测结果均为阴性。 结论: CNV-seq可有效检出胎儿DMD基因缺失或重复,但存在少量漏检风险,结果需MLPA验证。CNV-seq检测到chrX:32650635_32910000区域重复及检出覆盖DMD基因5′端或3′端重复的变异可能并不致病。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Qiu X, Guo JJ, Jin CC, et al. [Efficiency of CNV-seq in detecting fetal DMD gene deletion or duplication in prenatal diagnosis]. Zhonghua Fu Chan Ke Za Zhi. 2024. PMID: 38644274. doi:10.3760/cma.j.cn112141-20230919-00107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。